Chart 1.  Treatment guidelines for Premenstrual Dysphoric Disorder (PMDD)

Undertake a careful medical and psychiatric history.  Rule-out or treat any physical disorders (e.g. hypothyroidism).

↓

If premenstrual symptoms remain, obtain prospective mood ratings for 2-3 months. Rule-out premenstrual exacerbation of other psychiatric conditions.

↓

Diagnose with PMDD if the patient meets criteria after two consecutive cycles.  Encourage supportive counseling that advocates lifestyle adjustments during vulnerable premenstrual times.  Assess type and severity of symptoms.

↓

Mild symptoms:  use vitamins, minerals, evening primrose oil, or a diuretic  
·    May be taken for only part of the cycle (midcycle to the onset of menses)
·    
Vitamin B6: 25-100 mg per day (start with 25-50 mg per day; not to exceed
    100 mg per day)

·    Optivite, calcium, or magnesium may also have positive effects on mood
·    Potassium-sparing diuretics (e.g. hydrochlorothiazide 25 mg, triamterene 50 mg)
    are appropriate if a woman has significant weight gain premenstrually; monitor
    electrolytes closely
·    Bromocriptine in dosages of 1.25-7.5 mg per day may be appropriate if breast
    pain is a significant concomitant symptom

↓

Moderate to severe symptoms:  use psychotropic drugs or hormonal therapy
·    Improvement typically requires 2-4 months of treatment
·    SSRIs (e.g. fluoxetine 20-40 mg per day starting at 20 mg for 2-3 cycles,
    sertraline 50-100 mg per day,  clomipramine 25-75 mg per day, etc.) appear
    to be effective; consider intermittent dosing (e.g. from midcycle to the onset of
    menses) with significant side effects
·    Nortriptyline also may be beneficial
·    Hormonal options (e.g. GnRH agonists, danazol, and estradiol) may be effective
    but are not recommended as there currently is insufficent data about their safety
    in long-term use; progesterone and oral contraceptives do not appear to have a
    beneficial effect on depressive symptoms
·    Lithium or other mood stabilizers may be effective for recurrent, suicidal
    depression (check levels at different menstrual cycle phases)

↓

Anxious symptoms prominent with secondary dysphoria:  use anxiolytics
·    Alprazolam (start at .25 mg per day and increase as necessary; do not exceed
    4 mg per day; taper at the onset of menses by 25% per day) can be given
    during days 12-28 of the cycle
·    Clonazepam may be helpful for patients who cannot tolerate the abrupt tapering
·    Benzodiazepines may be used with caution during symptomatic days
·    Buspirone (start at 5 mg three times per day) may be used throughout the cycle
    or from midcycle to the onset of menses

Back to Chapter

published 2000